Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and internationally. The company offers artificial dura mater patches, craniofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also of...
Medprin Regenerative Medical Technologies reported revenue of 368.83 million CNY for fiscal year 2025, up 32.5% from fiscal year 2024, and net income of 113.13 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 78.36 million CNY, up 6.3% from a year before. Its largest business segment, Implanted Medical Devices, brought in 98% of segment revenue in fiscal year 2024; China was the largest region with 80%.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.